Devices in healthcare facilities support mission critical processes. Any issue that degrades network performance can have serious consequences.
Companies developing technologies that integrate AI need to consider regulatory concerns, community demographics, fitting into existing workflows, technical proficiency of both the hospital personnel and consumers.
While companies developing solutions that address the current pandemic may be receiving an influx of financial support, recovery for companies in other segments of the industry is slow.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
Augmented reality and extended reality will play a front-and-center role in patient care.
Artificial intelligence and machine learning are proving to be meaningful weapons in our arsenal during the coronavirus crisis.
The Chinese government is investing heavily in the development of new technologies that leverage AI. This includes solutions to address the COVID-19 outbreak.
Personalized medicine is the future of healthcare, and artificial intelligence will play a big role.
Treatment can no longer be one dimensional.
Medical device companies will be driven to evolve their business models to a more patient/consumer-centric approach.